MP™ Biomedical Drugs of Abuse Test Kits

Product Description

All of DOA Panel Test is a one-step in-vitro test based on immunochromatography. It is designed for qualitative determination of drug substances in human urine specimens. This assay may be used in the point of care setting with the following list of cutoff concentrations for each drug.
Amphetamine - 1000 ng/ml of d-amphetamine
Barbiturate - 300 ng/ml of secobarbital
Benzodiazepine - 300 ng/ml of oxazepam
Buprenorphine (Subutex) - 10 ng/ml of buprenorphine-3- -d glucoronide
Cocaine - 300 ng/ml of benzoylecgonine
Methadone - 300 ng/ml of methadone
Methamphetamine - 1000 ng/ml of (+)methamphetamine
Opiate* - 300 ng/ml of morphine
Opiate II* - 2000 ng/ml of morphine
Oxycodone - 100 ng/ml of oxycodone
Phencyclidine - 25 ng/ml of phencyclidine
Cannabinoid (THC) - 50 ng/ml of 11-nor-D9-THC-9-COOH

This assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/ mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. * SAMHSA recommends a cut-off concentration of 2000 ng/ml for Opiates Test.